GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cochlear Ltd (OTCPK:CHEOY) » Definitions » Cash Receipts from Operating Activities

CHEOY (Cochlear) Cash Receipts from Operating Activities : $1,481 Mil (TTM As of Dec. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Cochlear Cash Receipts from Operating Activities?

Cochlear's Cash Receipts from Operating Activities for the six months ended in Dec. 2024 was $754 Mil.

Cochlear's Cash Receipts from Operating Activities for the trailing twelve months (TTM) ended in Dec. 2024 was $1,481 Mil.


Cochlear Cash Receipts from Operating Activities Historical Data

The historical data trend for Cochlear's Cash Receipts from Operating Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cochlear Cash Receipts from Operating Activities Chart

Cochlear Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Cash Receipts from Operating Activities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 988.82 1,104.21 1,141.11 1,257.11 1,456.71

Cochlear Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cash Receipts from Operating Activities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 589.27 671.01 735.48 727.09 754.40

Cochlear Cash Receipts from Operating Activities Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Cash Receipts from Operating Activities represents cash received from operating activitiies in direct method.

GuruFocus lists following items in "Cash Receipts from Operating Activities" section for non-financial companies:
Receipts from Customers
Receipts from Government Grants
Other Cash Receipts from Operating Activities

Cash Receipts from Operating Activities for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $1,481 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cochlear Cash Receipts from Operating Activities Related Terms

Thank you for viewing the detailed overview of Cochlear's Cash Receipts from Operating Activities provided by GuruFocus.com. Please click on the following links to see related term pages.


Cochlear Business Description

Industry
Traded in Other Exchanges
Address
1 University Avenue, Macquarie University, Sydney, NSW, AUS, 2109
Cochlear is the leading cochlear implant device manufacturer with around 60% global market share. Developed markets contribute 80% of group revenue where cochlear implants are the standard of care for children with severe to profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2020, 49% of revenue came from the Americas, 35% from Europe, the Middle East, and Africa, and 16% from the Asia-Pacific segment.

Cochlear Headlines

From GuruFocus

Full Year 2019 Cochlear Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024

Full Year 2022 Cochlear Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024

Half Year 2022 Cochlear Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024

Cochlear Ltd's Dividend Analysis

By GuruFocus Research 03-20-2024

Cochlear Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024

Half Year 2023 Cochlear Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024

Full Year 2021 Cochlear Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024

Half Year 2021 Cochlear Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024